2nd Apr 2015 08:07
LONDON (Alliance News) - Tekcapital PLC Thursday said it has acquired the exclusive license to a patent for the measurement of glucose in saliva from Arizona State University, which it thinks will allow it to transform the way glucose is measured for patients with diabetes.
The university technology and intellectual property services company said the patent addresses the need for a safe, fast and non-invasive method and device to collect and sample glucose in saliva. The device can be used to collect fluid from the mouth and samples can then be processed to detect glucose, a metabolic product in saliva, using disposable biosensor strips.
"The directors believe this technology represents an important potential improvement for the repeated measurement of glucose in Type II diabetics, without requiring a blood sample from a finger prick, which is the current Food and Drug Administration standard glucometer method of measurement," said Tekcapital.
"The directors believe that a non-invasive, strip-based technology to measure glucose in saliva could be transformative to both patients and the glucose monitoring industry and if successful, may become one of the monitoring techniques of choice," the company added.
The self-monitoring of blood glucose is a significant industry that Tekcapital is trying to commercialise using this technology with one or more leading medical device companies that can benefit by making it easier and painless for diabetics to measure glucose.
No financial details were released regarding the acquisition of the patent.
Tekcapital shares were up 1.1% to 20.97 pence per share on Thursday morning.
By Joshua Warner; [email protected]; @JoshAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
TekCapital